Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-9-8
|
pubmed:abstractText |
Chlamydia trachomatis is the most prevalent bacterial sexually transmitted disease (STD) in the United States, with the highest rates reported among adolescents. Chlamydia has severe consequences including pelvic inflammatory disease and infertility, and is believed to be a cofactor in human immunodeficiency virus transmission. Given that chlamydia is predominantly asymptomatic, most cases are identified through routine screening in health care settings. Over time, screening and treatment appear to be associated with a decrease in the prevalence of disease in areas with consistent chlamydia control programs. The new availability of sensitive and specific urine tests for chlamydia (polymerase chain reaction [PCR] and ligase chain reaction [LCR]) provides the opportunity to screen large numbers of at-risk youth in a noninvasive manner. We used PCR/LCR testing to investigate the feasibility of a school-based chlamydia control program and to determine the prevalence of chlamydia infection among junior and senior high school students.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1098-4275
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
E1
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9417165-Adolescent,
pubmed-meshheading:9417165-Adult,
pubmed-meshheading:9417165-Anti-Bacterial Agents,
pubmed-meshheading:9417165-Azithromycin,
pubmed-meshheading:9417165-Chlamydia Infections,
pubmed-meshheading:9417165-Chlamydia trachomatis,
pubmed-meshheading:9417165-DNA, Bacterial,
pubmed-meshheading:9417165-DNA Ligases,
pubmed-meshheading:9417165-Female,
pubmed-meshheading:9417165-Gene Amplification,
pubmed-meshheading:9417165-Humans,
pubmed-meshheading:9417165-Louisiana,
pubmed-meshheading:9417165-Male,
pubmed-meshheading:9417165-Polymerase Chain Reaction,
pubmed-meshheading:9417165-Prevalence,
pubmed-meshheading:9417165-Schools,
pubmed-meshheading:9417165-Sensitivity and Specificity,
pubmed-meshheading:9417165-Urban Population,
pubmed-meshheading:9417165-Urine
|
pubmed:year |
1998
|
pubmed:articleTitle |
A school-based Chlamydia control program using DNA amplification technology.
|
pubmed:affiliation |
Louisiana State University Medical Center, New Orleans, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|